Toggle navigation
Home
About Us
About GH Medical
Mission Statement
Meet the Team
White Paper
Disclaimer
Partners
Contact Us
Education
Introduction to cannabis-based medicine
What are cannabinoids?
How do cannabinoids work
Route of application
Cannabinoid receptor activation
Cannabinoid distribution in your body
Cannabinoid degradation
Variation in the endocannabinoid system
Natural versus synthetic cannabinoids
Generic prescription advice
Adverse effects and countermeasures
Cannabinoid dose calculation tool
Diseases
Reproduction and Development
Summary
Testicles – spermatogenesis
Ovaries Ovulation
Sex Drive
Pregnancy/placenta
Fetal development
Lactation
Neonatal development
Adolescence
Adult brain
Transgenerational effects
Epidemiological Studies
Cannavigator
Therapeutic Cannavigator (beta)
Cannavigator Project
Patient Survey
Select Language
English
Arabic
Cebuano
Croatian
Czech
Danish
Dutch
Estonian
Finnish
French
German
Greek
Norwegian
Portuguese
Russian
Spanish
NADA
STEARDA
Submitted by
heiko@ghsctradi...
on Mon, 03/14/2016 - 13:14
STEARDA
is an
endocannabinoid
with weak
CB1
affinity.
Read more
about STEARDA
NADA
Submitted by
heiko@ghsctradi...
on Mon, 03/14/2016 - 13:14
Suspected
endocannabinoid
.
Read more
about NADA
first
previous
1
2
